Earnings History Data for NeuBase Therapeutics, Inc. (NBSE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NeuBase Therapeutics, Inc.

NeuBase Therapeutics Inc. is a biotechnology company. It is engaged in developing antisense therapies to address genetic diseases. The company's proprietary platform includes PATrOL(TM). NeuBase Therapeutics Inc., formerly known as Ohr Pharmaceutical Inc., is based in Pittsburgh, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-02-2023	AH		NBSE	NeuBase Therapeutics	11.00	-0.13	-0.11	0.00	NeuBase Therapeutics GAAP EPS of -$0.13 misses by $0.02 [2/14/2023 4:52 PM]	0.2888	-0.07 (-19.44%)	0.32	-0.04 (-10.74%)	0.17 - 2.08	602,677	770,000	10,883
NeuBase Therapeutics GAAP EPS of -$0.13 misses by $0.02 [2/14/2023 4:52 PM]
21-12-2022	PM		NBSE	NeuBase Therapeutics	6.00	-0.24	-0.27	0.00	NeuBase Therapeutics GAAP EPS of -$1.04 beats by $0.04 [12/21/2022 8:21 AM]	0.2001	0.01 (5.43%)	0.21	0.02 (10.64%)	0.17 - 3.18	258,890	180,000	1,067
NeuBase Therapeutics GAAP EPS of -$1.04 beats by $0.04 [12/21/2022 8:21 AM]
10-02-2022	PM		NBSE	NeuBase Therapeutics, Inc.	48.43	-0.24	-0.25	-0.18	NeuBase Therapeutics GAAP EPS of -$0.24 [2/11/2022 12:40 AM]	1.40	0.09 (6.87%)	1.36	0.05 (3.82%)	1.23 - 12.47	280,640	180,000	1,005
NeuBase Therapeutics GAAP EPS of -$0.24 [2/11/2022 12:40 AM] NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2022 [Feb-10-22 07:00PM]
13-05-2021	AH	4:00 PM ET (May 13)	NBSE	NeuBase Therapeutics, Inc.	158.99	-0.24	-0.23	-0.26	NeuBase Therapeutics reports Q1 results [5/13/2021 5:12 PM]	5.06	0.42 (9.05%)	4.64	0.0 (0.00%)	4.51 - 12.89	305,112	360,000	4,895
NeuBase Therapeutics reports Q1 results [5/13/2021 5:12 PM] NeuBase Therapeutics Appoints Gerald J. McDougall to Board of Directors [May-12-21 09:00AM] NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021 [May-13-21 04:05PM] NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021 [May-14-21 12:31PM]
11-02-2021	AH		NBSE	Neubase Therapeutics, Inc.	286.00	-0.18	-0.24	0.00	NeuBase Therapeutics EPS beats by $0.05 [2/11/2021 4:58 PM]	11.74	0.61 (5.48%)	11.40	0.27 (2.43%)	4.52 - 12.89	390,885	354,626	515
NeuBase Therapeutics EPS beats by $0.05 [2/11/2021 4:58 PM]
23-12-2020	AH		NBSE	Ohr Pharmaceuticals, Inc.	188.00	-0.20	-0.20	0.00	NeuBase Therapeutics EPS in-line [12/23/2020 4:08 PM]	7.64	-0.23 (-2.92%)	7.95	0.08 (1.02%)	4.52 - 11.78	159,010	332,195	265
NeuBase Therapeutics EPS in-line [12/23/2020 4:08 PM] NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020 [Dec-23-20 04:05PM]
23-12-2020	AH		NBSE	NeuBase Therapeutics, Inc.	188.22	-0.20	-0.20	0.00	NeuBase Therapeutics EPS in-line [12/23/2020 4:08 PM]	7.64	-0.23 (-2.92%)	7.95	0.08 (1.02%)	4.52 - 11.78	159,010	332,195	265
NeuBase Therapeutics EPS in-line [12/23/2020 4:08 PM] NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020 [Dec-23-20 04:05PM]